Commission Implementing Regulation (EU) 2026/2390 of 28 October 2026 making imports of acetylsalicylic acid originating in the People’s Republic of China subject to registration with a view to allowing the levy of anti-dumping duties on the imports subject to registration
Preámbulo 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union ( 1 ) (‘the basic Regulation’) and in particular Article 14(5) thereof,
After informing the Member States,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) On 23 September 2026, the European Commission (‘the Commission’) announced, by a notice published in the Official Journal of the European Union ( 2 ) , the initiation of an anti-dumping proceeding with regard to imports into the Union of acetylsalicylic acid originating in the People’s Republic of China (‘China’).
recital 2recital 2
(2) This initiation followed a complaint lodged on 10 August 2026 by Novacyl SAS on behalf of producers representing more than 25 % of the total Union production of acetylsalicylic acid.
recital 3recital 3
1. PRODUCT SUBJECT TO REGISTRATION
(3) The product subject to registration (‘the product concerned’) is o-acetylsalicylic acid (CAS RN 50-78-2) originating in China.
recital 4recital 4
(4) The product concerned is currently classified under CN code ex 2918 22 00 (TARIC code 2918 22 00 20).
recital 5recital 5
2. REGISTRATION
(5) Under Article 14(5) of the basic Regulation, imports of the product concerned may be made subject to registration.
recital 6recital 6
(6) The purpose of registration is to ensure that anti-dumping duties, if any, can be levied retroactively on the imports subject to registration in accordance with the applicable legal provisions, if the necessary conditions are met.
recital 7recital 7
(7) The Commission has decided to make imports of the product concerned subject to registration on its own initiative under Article 14(5) of the basic Regulation. The conditions for retroactive collection of duties, if any, will be assessed in the regulation imposing definitive duties.
recital 8recital 8
(8) Any future liability would emanate from the findings of the anti-dumping investigation.
recital 9recital 9
(9) The calculations provided in the complaint requesting the initiation of an anti-dumping investigation estimate dumping margins between 20 % and 45 % and an injury elimination level between 49 % and 78 % for the product concerned for the period from 1 January 2025 to 31 December 2025. The amount of possible future liability would normally be set at the lower of the dumping or injury level according to Article 9(4) of the basic Regulation.
recital 10recital 10
(10) However, at this stage the Commission is not in a position to estimate the amount of possible future liability. Thus, the amounts mentioned in the complaint are only for information purposes and cannot create any expectations as to the actual level of liability which will be established as a result of the investigation.
recital 11recital 11
3. PROCESSING OF PERSONAL DATA
(11) Any personal data collected in the context of this registration will be treated in accordance with Regulation (EU) 2018/1725 of the European Parliament and of the Council ( 3 ) ,
Artículo 1
1. The customs authorities are hereby directed, under Article 14(5) of Regulation (EU) 2016/1036, to take the appropriate steps to register imports into the Union of o-acetylsalicylic acid (CAS RN 50-78-2), currently classified under CN code ex 2918 22 00 (TARIC code 2918 22 00 20) and originating in China.
2. Registration shall expire nine months following the date of entry into force of this Regulation.
Artículo 2
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .